Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7–8 in human breast cancer
- 31 October 1996
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (11) , 2023-2025
- https://doi.org/10.1016/0959-8049(96)00185-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Differential CD44 expression patterns in primary brain tumours and brain metastasesBritish Journal of Cancer, 1995
- Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIBGynecologic Oncology, 1995
- CD44 variant exon epitopes in primary breast cancer and length of survivalThe Lancet, 1995
- Preferential Expression of the Cell Adhesion Molecule CD44 in Papillary Thyroid CarcinomaExperimental and Molecular Pathology, 1994
- CD44 splice variants: metastases meet lymphocytesImmunology Today, 1993
- Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphomaBritish Journal of Cancer, 1993
- Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44Science, 1992
- Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.Journal of Clinical Investigation, 1991